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The interaction between natural killer (NK) cells and different other immune cells like T cells
and dendritic cells is well-described, but the crosstalk with monocytes or macrophages
and the nature of ligands/receptors implicated are just emerging. The macrophage-NK
interaction is a major first-line defense against pathogens (bacteria, viruses, fungi, and
parasites). The recruitment and the activation of NK cells to perform cytotoxicity or
produce cytokines at the sites of inflammation are important to fight infections. The two
main mechanisms by which macrophages can prime NK cells are (1) activation through
soluble mediators such as IL-12, IL-18, and (2) stimulation through direct cell-to-cell contact.
We will discuss the progress in matters of modulation of NK cell functions by monocytes
and macrophages, in the steady state and during diseases.
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INTRODUCTION
Resident macrophages derive from circulating monocytes.
Their differentiation occurs upon entering the tissues where
macrophages show heterogeneous phenotypes depending on
local microenvironments (Taylor et al., 2005). Macrophages are
found in lymphoid as well in non-lymphoid organs like liver
(Kuppfer cells), lung (alveolar macrophages), nervous system
(microglia), reproductive organs, and in the lamina propria of the
gut (Taylor et al., 2005; Richards et al., 2012). When pathogens
infect specific organs, one of the earliest cell types to arrive at the
site of infection is natural killer (NK) cells in partnership with
macrophages. Important differences have been shown among the
molecular mechanisms for NK cell activation by microorganisms
(including viruses, bacteria, and protozoans) involving inhibitory
and activating receptors (Newman and Riley, 2007; Horowitz
et al., 2011). The recognition and lysis of target cells by NK cells
pass through sensing “missing self” due to the lack of MHC class
I molecules and through interaction of activating receptors with
specific ligands.
How does the interaction between monocytes or macrophages
and NK cells trigger immune response? Both cell to cell con-
tact and soluble mediators contribute to the activation of NK
cells. A new understanding of NK cell responses in health and in
infectious diseases is emerging where macrophages play a crucial
intermediary role. Here we summarize recent data regarding the
molecular interactions that regulate the monocyte/macrophage-
dependent activation of NK cells.
MACROPHAGE/NK INTERACTIONS BY CELL-TO-CELL
CONTACT: WHICH RECEPTORS ARE IMPLICATED?
In human and mouse models, a simple coculture of monocytes
or macrophages with NK cells increases CD69 expression in NK
cells, showing that the former can activate NK cells in vitro (Haller
et al., 2002; Dalbeth et al., 2004; Scott et al., 2004). This activation
is cell-contact-dependent and enhances the secretion of IFN-γ by
NK cells (Haller et al., 2002; Atochina and Harn, 2005). Several
groups have shown an upregulation of CD69 at the NK cell
surface, the production of IFN-γ and the degranulation of NK
cells when monocytes/macrophages were previously stimulated
by molecules like Lacto-N-fucopentaose III, poly I:C, CpG DNA,
and LPS (Chace et al., 1997; Scott et al., 2004; Atochina and Harn,
2005; Basu et al., 2009; Bellora et al., 2010; Zhou et al., 2012).
Infection by parasites, like P. falciparum and Leishmania (Aranha
et al., 2005; Baratin et al., 2005), or viruses, like influenza A virus,
Sendai virus, human cytomegalovirus (Siren et al., 2004; Romo
et al., 2011), or bacteria like Salmonella, M. tuberculosis, E. fae-
calis, S. aureus, Lactobacillus, S. pneumonia, and B. anthracis, has
the same effects (Brill et al., 2001; Haller et al., 2002; Schierloh
et al., 2005; Denis et al., 2007; Newman and Riley, 2007; Lapaque
et al., 2009; Takayama et al., 2010; Elhaik-Goldman et al., 2011;
Klezovich-Benard et al., 2012; Souza-Fonseca-Guimaraes et al.,
2012).
The dialog between monocytes or macrophages and NK cells
via cellular contacts enhances NK cell activity. Depending on
the pathogen, different types of receptors present at the NK cell
surface respond to the stimulated macrophages (Table 1).
CD154-CD40 INTERACTIONS
In mice, the CD40-CD40L (CD154) interactions participate
in driving the activation of NK cells by LPS- or Lacto-N-
fucopentaose III-activated macrophages in vitro (Table 1) (Scott
et al., 2004; Atochina and Harn, 2005).
NKG2D INTERACTIONS
In human, the presence of high doses of LPS changes the phe-
notype of macrophages by inducing the expression of various
ligands of the activating receptor NKG2D: UL16-binding proteins
(ULBP1, ULBP2, and ULBP3) and MHC class I-related chain A
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Table 1 | Ligand-receptor families implicated in activation of NK cells by monocytes/macrophages.
Stimulated with Monocyte/macrophage
ligands
NK receptors Species Selected références
Various pathogens CD69 Human, mouse Scott et al., 2004; Haller et al., 2002;
Dalbeth et al., 2004
LPS, Lacto-N fucopentaose III CD40 CD154 Mouse Scott et al., 2004; Atochina and Harn,
2005
Cytomegalovirus CD48 2B4 Human Bellora et al., 2010; Romo et al., 2011;
Nedvetzki et al., 2007
LPS, M. Tuberculosis poly I:C ULBP1-3 MICA NKG2D Human, mouse Nedvetzki et al., 2007; Kloss et al.,
2008; Hamerman et al., 2004; Basu
et al., 2009; Hou et al., 2009;
Vankayalapati et al., 2005
Influenza A virus, Sendai virus MICB NKG2D Human Siren et al., 2004
LPS, lipopeptide Pam3CSK4,
zymosan, poly I:C, B.
anthracis spores
RAE-1 NKG2D Mouse Hamerman et al., 2004;




NKp46 Human, mouse Hou et al., 2009; Elhaik-Goldman et al.,
2011; Romo et al., 2011
NKp30, NKp44 Human Nedvetzki et al., 2007
LPS, lipopeptide Pam3CSK4,
poly l:C
AICL NKp80 Human Welte et al., 2006
Poly l:C Qa-1 NKG2A Mouse Zhou et al., 2012
(MICA) (Nedvetzki et al., 2007). Human NK cells which are in
contact with macrophages or LPS-activated macrophages express
increased levels of NKG2D. However, NKG2D expression in NK
cells seems to be less induced by LPS-activated macrophages
than unactivated macrophages (Nedvetzki et al., 2007). This phe-
nomenon could be similar to the observation that prolonged
exposure to its ligands induces a downregulation of NKG2D
on NK cells (Ogasawara et al., 2003; Hamerman et al., 2004;
Coudert et al., 2005; Kloss et al., 2008; Lapaque et al., 2009). These
receptor-ligand interactions induce the lysis of macrophages
stimulated with high doses of LPS, by NK cells via NKG2D
(Nedvetzki et al., 2007). Thus, NK cells specifically kill PBMC-
derived macrophages stimulated with high doses of LPS proba-
bly to eliminate overstimulated macrophages to avoid endotoxic
shock. On the contrary, LPS-stimulated microglia (nerve system
macrophages) is less susceptible to NK cell-mediated cytotoxicity
compared to resting microglia. The killing of resting microglial
cells by NK cells is reduced by NKG2D-specific blocking Abs,
meaning that NKG2D is involved in this process. Furthermore,
NKG2D ligands are expressed constitutively by microglia cells
in vitro. However, in LPS-stimulated microglia this expression
is down-regulated. By this mechanism, activated microglial cells
which are not lysed by NK cells could be able to present anti-
gens to infiltrating T cells and initiate a limited immune response
in the brain (Lunemann et al., 2008). Another study on mono-
cytes described that the killing of MICA-expressing monocytes
by autologous NK cells is not observed neither in the presence
nor in the absence of LPS (Kloss et al., 2008). In presence of
LPS, MICA is up-regulated on monocytes. Differences between
these various cell types show that macrophages, microglia, and
monocytes are not equally susceptible to NK cell-mediated killing
after LPS-stimulation. This could be the result of a variation
in the level of inhibitory and activating signals from these tar-
get cells to NK cells. This might be explained by the difference
of NKG2D engagement and different levels of the counterbal-
ance due to MHC class I binding of inhibitory NK cell receptors.
Indeed, in presence of LPS, PBMC-derived macrophages are not
associated with an MHC class I up-regulation while this is the
case for microglia and monocytes (Nedvetzki et al., 2007; Kloss
et al., 2008; Lunemann et al., 2008). NKG2D is also required in
other organs but the nature of its ligand differs depending on the
type of infection. Thus, poly I:C stimulated uterine macrophages
up-regulate MICA and activate IFNγ production of uterine NK
cells through the recognition of NKG2D (Basu et al., 2009).
Likewise, alveolar macrophages infected by M. tuberculosis are
lysed by NK cells via the interaction between NKG2D and ULBP1
(Vankayalapati et al., 2005). Another NKG2D ligand, MICB, is
expressed when human macrophages are infected with influenza
A or Sendai viruses and the infected macrophages are likely to
promote IFN-γ release by NK cells (Siren et al., 2004).
In mice, similar pathways can be found to initiate the acti-
vation of NK cells. Thus, peritoneal macrophages treated with
poly I:C increase NKG2D expression in NK cells (Zhou et al.,
2012). In response to Toll-like receptor (TLR) ligands like LPS,
lipopeptide Pam3CSK4, zymosan, or poly I:C, retinoic acid early
inducible-1 (RAE-1) is induced in macrophages (Hamerman
et al., 2004). After contact with RAE-1, the NKG2D receptor
triggers activation of NK cell cytotoxicity-related molecules, TNF-
related apoptosis-inducing ligand (TRAIL), perforin and FasL
and therefore the induction of NK cell cytotoxicity toward tumor
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cells and the secretion of IFN-γ (Hou et al., 2009; Zhou et al.,
2012). RAE-1-NKG2D interactions are also involved to stimu-
late the release of IFN-γ by NK cells during the crosstalk with
monocytic myeloid derived suppressor cells (MDSC) (Nausch
et al., 2008). The same RAE-1-NKG2D engagement is observed
between bone marrow-derived macrophages and NK cells in
response to B. anthracis spores (Klezovich-Benard et al., 2012).
Thus, the NKG2D pathway has its importance to confer pro-
tection against infections, as it indirectly detects a wide vari-
ety of pathogens through the recognition of various NKG2D
ligands.
2B4-CD48 INTERACTIONS
In human, the release of IFN-γ by NK cells can be trig-
gered by the interaction of the receptor 2B4 with the ligand
CD48 present at the surface of PBMC-derived macrophages
(Nedvetzki et al., 2007; Bellora et al., 2010; Romo et al.,
2011). This engagement depends on how macrophages have
been prearmed. Macrophages stimulated with high doses of
LPS activate NK cytotoxicity rather than cytokine release. When
the latter have not been activated or activated with low doses
of LPS, the system passes through the 2B4-CD48 pathway.
The 2B4-CD48 engagement has other consequences like the
increase of the expression of 2B4 and the proliferation of
NK cells (Nedvetzki et al., 2007). Thus, after contact with
macrophages, 2B4 induces NK cell cytokine secretion and pro-
liferation. However, depending on the cell types, the signaling
triggered by 2B4 could also result in activation of NK cytotox-
icity, which could be due to a different 2B4 isoform expression
(Mathew et al., 2009; Kim et al., 2010). When macrophages are
infected by human cytomegalovirus, the expression of CD48
is down-regulated, suggesting the existence of a potential viral
immune escape strategy targeting the 2B4 pathway (Romo et al.,
2011).
IMMUNE SYNAPSES
One group has investigated the structure of the immune synapses
between macrophages and NK cells in the context of LPS-
stimulation (Nedvetzki et al., 2007). Images of the macrophage-
NK cell conjugates show an accumulation of F-actin at the site
of contact which is more frequent when macrophages are stim-
ulated with high doses of LPS. The accumulation of F-actin
at cytolytic synapses between NK cells and LPS-stimulated
macrophages happens at the NK cell side, while F-actin accu-
mulates at the macrophage side in the non-cytolytic synapses
in absence of LPS. Thus, the NK cell-macrophage commu-
nication is different depending on whether macrophages are
treated or not with high doses of LPS. Indeed, the activat-
ing receptor complex NKG2D/DAP10, the activating adaptor
protein CD3ζ as well as ICAM-1 are recruited to the NK
cell immune synapse by macrophages stimulated with high
doses of LPS and very rarely by unactivated macrophages,
showing a key role of these molecules in triggering cytotoxi-
city. On the other hand, a large fraction of 2B4 clustered to
the immune synapse of macrophages and macrophages acti-
vated with low doses of LPS, confirming the concept that this
receptor is important for the macrophage-mediated NK cell
proliferation and IFN-γ secretion. Two distinct NK cell synapses
are defined, one activating the proliferation and cytokine secre-
tion, by the recruitment of 2B4, and the other one trigger-
ing lysis through the activation of NKG2D (Nedvetzki et al.,
2007).
NKp46-DNAM-1 INTERACTIONS
In human, the susceptibility of macrophages to be lysed by
autologous NK cells can also be mediated by the activating
receptors NKp46 and DNAM-1. Thus, blocking of NKp46 and
DNAM-1 decreases NK cell cytotoxicity against cytomegalovirus-
infected macrophages and LPS-stimulated macrophages derived
from PBMC. NKp46 is also involved in the lysis ofM. tuberculosis-
infected alveolar macrophages (Vankayalapati et al., 2005; Bellora
et al., 2010; Romo et al., 2011). In the case of resting microglial
cells, only NKp46 engagement is implicated in the killing
(Lunemann et al., 2008). Furthermore, the coculture of NK
cells and PBMC-derived macrophages increases the expression
of NK activating receptors like NKp30, NKp44, and NKp46
(Nedvetzki et al., 2007). In regard of the different data reported,
it seems that NKp46 participates mainly to NK cell cytolytic
activity whereas 2B4 is rather involved in the induction of IFN-
γ production. DNAM-1 plays quite a dual role, as it seems
to participate to the activation of both cytotoxicity and IFN-γ
secretion.
In contrast to human, the expression of mouse NKp46
and DNAM-1 is not increased in the presence of peritoneal
macrophages treated with poly I:C (Zhou et al., 2012). However,
in another context, NCR1 (mouse NKp46) is shown to be
involved in the macrophage-NK cell crosstalk, as alveolar
macrophages infected in vitro by S. pneumoniae mediate lung
NK cell activation (CD107a expression and IFN-γ secretion) in
part through the NCR1 receptor pathway (Elhaik-Goldman et al.,
2011).
Other molecules, like CD44 and ICAM-1, could be involved in
macrophage-NK cell interactions, but their precise role remains
to be determined (Nedvetzki et al., 2007).
NKp80-AICL INTERACTIONS
In human, PBMC-derived macrophages and monocytes express
the activation-induced C-type lectin (AICL). Monocytes acti-
vated through their TLR by LPS, lipopeptide Pam3CSK4, or poly
I:C increase the expression of AICL at their surface. AICL is the
ligand of the NK cell activating receptor NKp80. The interac-
tion AICL-NKp80 leads to the secretion of IFN-γ by NK cells
(Welte et al., 2006). TLR-induced AICL expression may act to
eliminate monocytes or macrophages exposed to or infected by
microorganisms.
NKG2A-Qa-1 INTERACTIONS
Both activating and inhibitory surface receptors participate in the
regulation of NK cell activities. Thus, Qa-1, the ligand of the
inhibitory receptor NKG2A is upregulated at the surface of poly
I:C stimulated-macrophages. However, the NKG2A level does not
change when NK cells are cocultured with these macrophages.
The Qa-1-NKG2A interactions allow the macrophages to escape
to lysis by NK cells (Zhou et al., 2012).
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MACROPHAGE/NK INTERACTIONS THROUGH SOLUBLE
FACTORS
The first observations of cytokines being secreted bymacrophages
and influencing NK cell functions are from the early 1990s
(Lemaire and St-Jean, 1990; Tripp et al., 1993; Lauzon and
Lemaire, 1994). In 1993, Tripp et al. observed that Listeria mono-
cytogenes is phagocytosed by peritoneal macrophages, which then
release TNF-α and IL-12 resulting in the production of IFN-
γ by NK cells (Tripp et al., 1993). The following year, another
team showed that alveolar macrophages inhibited lung NK cell
activities through the release of TGF-β1 (Lauzon and Lemaire,
1994).
IL-12, IL-18 MESSENGERS
More recently, the proinflammatory cytokines IL-6, IL-12, IL-18,
and TNF-α were observed in cultures of mouse spleen NK cells
and peritoneal macrophages (Scott et al., 2004). The cytokine
production between single cell-type cultures and cocultures
showed no differences except a decrease of the IL-6 secretion by
macrophages when they were in contact with NK cells. However,
the inhibition of IL-12 secretion from activated macrophages has
no influence on NK cell function during bacterial peritonitis
(Scott et al., 2004). Thus, the potential activators IL-12 and IL-
18 do not play a major role in NK cell activation by macrophages
under these conditions. On the contrary, the secretion of IL-12
by CpG DNA or B. anthracis-infected macrophages enhances the
release of IFN-γ by mouse NK cells but needs in addition a cell-
to-cell contact (Chace et al., 1997; Klezovich-Benard et al., 2012).
Moreover, IL-12 and IL-18 are involved in the crosstalk between
Kupffer cells (liver resident macrophages) and NK cells after poly
I:C treatment in mice (Hou et al., 2009).
The same capacity of IL-12 and IL-18 secreted by Kupffer
cells to activate IFN-γ production by liver NK cells is found in
human (Tu et al., 2008). The key role of IL-12 and IL-18 in NK
cytotoxicity is confirmed in an experiment where PBMC-derived
macrophages are infected with Salmonella (Lapaque et al., 2009).
Furthermore, LPS, in presence of PBMC-derived macrophages,
promotes the expression of IL-18 and consequently the synthe-
sis of IFN-γ by NK cells (Bellora et al., 2012). Finally, S. aureus
stimulated-monocytes from PBMC, produce IL-12 which partic-
ipates to IFN-γ secretion by NK cells (Figure 1) (Haller et al.,
2002).
IL-15 MESSENGER
On the other hand, the release of the proinflammatory cytokine
IL-15 by mouse poly I:C-stimulated macrophages, also promotes
the production of IFN-γ and the expression of CD69 by NK
cells (Zhou et al., 2012). Furthermore, macrophages isolated from
lungs infected by S. aureus represent a source of IL-15 capable
to induce TNF-α production by NK cells (Small et al., 2008).
Another team has recently shown that mice infected by L. mono-
cytogenes have inflammatory monocytes and subsets of spleen
FIGURE 1 | Different macrophage-derivated signals that influence NK cell functions.
Frontiers in Immunology | NK Cell Biology January 2013 | Volume 3 | Article 403 | 4
Michel et al. Macrophage-NK cell interactions
macrophages which mediate granzyme B and IFN-γ secretion
by NK cells in vivo (Soudja et al., 2012). After detection of dif-
ferent classes of microbial pathogens, activated monocytes and
macrophages upregulate and trans-present IL-15 to NK cells.
IL-23 MESSENGER
Recently, a study described that IFN-γ–producing NKp46+ NK
cells were increased in the intestine of patients with Crohn’s dis-
ease. The production of IFN-γ by these cells is stimulated by the
secretion of IL-23 and by cell-to-cell contact with the CD14+
lamina propria macrophages in response to stimulation with
E. faecalis (Takayama et al., 2010). IL-23 may be involved as a key
mediator in gut-specific inflammation.
IL-10 MESSENGER
Monocytes have also the capacity of a net inhibitory effect on NK
cell activation through the release of IL-10 after an infection with
M. tuberculosis and a depletion of these monocytes will increase
the secretion of IFN-γ by NK cells (Schierloh et al., 2005).
The cytokines released by monocytes and macrophages to
mobilize NK cells require the recognition of “danger” molecules
by innate immune receptors. Then the triggering of pathways
which involve NK-cell mediated IFN-γ release will promote the
expression of antimicrobial functions of effector cells to protect
from pathogens (Figure 1).
INFLUENCE OF THE TISSUE ENVIRONMENT
The outcome of the interaction between macrophages and NK
cells is depending on their tissue localization (Zoller and Matzku,
1982; Raz, 2007). Indeed macrophages derived from PBMC have
not the same phenotype than macrophages localized in liver.
There is lower expression of HLA class I and greater expres-
sion of HLA class II molecules on Kupffer cells (Tu et al., 2008).
The same phenomenon is observed for NK cells. Indeed NK
cells from the liver are phenotypically different from blood NK
cells due to an absence of CD16 expression (Tu et al., 2008).
Mouse NK cells from lung and spleen are quite different and
react differently in contact with spleen or lung macrophages.
Spleen macrophages have the tendency to induce a stronger acti-
vation of NK cell cytotoxicity than lung macrophages (Michel
et al., 2012). Furthermore, depending on the tissue environment,
human macrophages are polarized toward either M1 or M2 sub-
sets which display different functionality (Biswas and Mantovani,
2010). LPS stimulation induces a change of unpolarized (M0) and
M2 macrophages toward an M1 phenotype and then leads to a
strong activation of autologous NK cells (Bellora et al., 2010).
Furthermore, human cytomegalovirus infected M1 macrophages
secrete IL-6, IL-12, TNF-α, and IFN-γ whereas M2 macrophages
produce only low levels of TNF-α, IFN-γ, and IL-10 (Romo
et al., 2011) The emerging complexity of interactions between NK
cells and macrophages makes the understanding of the pathways
implicated in vivo in steady state or during infection an ongoing
challenge.
CONCLUDING REMARKS
Activation of NK cells by many pathogens is triggered in part by
signals coming from macrophages. The precise molecular inter-
actions that underlie macrophages and NK cell communication
need to be further investigated. It will be interesting to better
define which implications this crosstalk might have on the adap-
tive immune response regarding the complex interactions of the
different partners involved.
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